You found a tick. Now the clock is running.

Over one million people contract Lyme Disease in Europe and the US each year — with experts placing true incidence five to ten times above reported figures. We estimate over 150 million annual tick bites (stings) in Europe and the US - each person stung faces insecurity about infection risk. Climate change has extended the tick season year-round and pushed ticks into regions that were previously safe. The problem is growing, not stabilising.

Treated early, Lyme Disease is a straightforward antibiotic course. Left undetected, it spreads silently — reaching the nervous system, the joints, the heart within weeks. An infection can turn chronic quickly. Time is the single most critical variable.

Until now, a person bitten by a tick had three options: wait for symptoms to appear, take prophylactic antibiotics they may not need, or send the tick to a lab — and receive results too late for the window where treatment works. For days or weeks, uncertainty was the default.

BorreTest tests the tick itself, not the person. It detects Borrelia DNA directly — bypassing the antibody-timing window entirely. Result in under 60 minutes, at clinical-grade sensitivity. No blood draw. No doctor visit. No waiting.

Parents and anyone spending time outdoors — people who already know the risk and have been waiting for a solution.

Employers in forestry, construction, agriculture, and outdoor sports with a legal duty to protect workers from tick-borne disease.

And doctors who, until now, could only advise patients to wait and watch — and can now give them an answer within the hour.

They are not waiting to be educated. They are waiting for the product.